Articles tagged with Osteoarthritis
Researchers discovered that moderate-intensity exercise significantly improved cartilage health and tissue resilience in aging-related osteoarthritis. The molecular cargo of extracellular vesicles was found to be enriched with microRNA-29, which restored youthful characteristics in cartilage cells and reduced joint degeneration features.
Low-dose radiation therapy may slow the progression of knee osteoarthritis, with sustained improvements in pain, physical function, and quality of life. The therapy was associated with a 67% lower adjusted hazard of government-certified disability due to knee osteoarthritis, particularly in patients with grade 2 disease.
The RACER-Knee trial found that robotic-assisted knee replacement surgery resulted in similar patient outcomes as traditional surgery, including recovery, mobility, and pain levels. Despite increased precision, the technology did not translate to improved patient outcomes within the first year after surgery.
Researchers have found a new compound that promotes joint health and reduces inflammation-related genes in a model of osteoarthritis. The drug, M04, has shown promise as an innovative OA therapy by slowing down the disease process, giving people more years of pain-free living.
A new study investigates the efficacy of stem cell injections for treating knee osteoarthritis, finding that MSC potency can be predicted through lab-based tests. Patients who showed improved pain and mobility scores had MSCs with enhanced anti-inflammatory effects.
Exercise produces small improvements in pain and physical function for people with hip osteoarthritis, but those improvements may not be large enough to make a meaningful difference in daily life. Quality of life showed little to no improvement with exercise.
Researchers have successfully mapped the cells and genes that regulate bone formation and loss, revealing blood vessel cells play a critical role in bone health. The discovery has the potential to enable the development of new therapies to reverse bone loss and improve treatments for osteoporosis and other skeletal conditions.
A new study published in Radiology found that embolization of abnormal blood vessels using rapidly resorbable gelatin-based microspheres is safe and effective in providing significant, lasting pain relief and functional improvement for patients with osteoarthritis-related knee pain. The procedure significantly reduces inflammation and ...
Researchers discovered that exercise enhances oxygen delivery to arthritic joints through tiny vesicles released from red blood cells, relieving tissue hypoxia and promoting joint health. Physical activity drives the circulation of these EVs into the joint, where they deliver oxygen and maintain joint function.
Analysis of medical records data found that GLP-1 receptor agonist drugs, used for diabetes and weight loss, are associated with a significantly lower risk of knee replacement surgery. The greatest effects were seen with sustained use and newer agents semaglutide and tirzepatide.
A University of Michigan research team is exploring the development of knee exoskeletons to reduce joint contact forces and relieve osteoarthritis pain. Preliminary testing suggests that these orthotic brace-based exos and drone-style motors could provide significant relief.
A new study suggests that ultrasound stimulation can bring about functionally meaningful changes in pain perception and brain connectivity. The research found a delayed analgesic effect, with participants reporting reduced pain intensity after 28-55 minutes following TUS application.
A pioneering study by the University of Eastern Finland confirms that total hip arthroplasty leads to better outcomes than conservative treatment for patients with moderate-to-severe hip osteoarthritis. The surgery significantly improved pain, functional capacity, and quality of life compared to conservative treatment alone.
A study mapped early molecular and cellular changes in the jaw joint that may trigger temporomandibular joint osteoarthritis. The research found structural and molecular changes in joint tissues, including inflammation, fibrosis, and metabolic shifts. Single-cell sequencing revealed diverse cell populations interacting within the synov...
City St George's, University of London, is partnering with Paradigm Biopharmaceuticals to test a potential treatment for osteoarthritis. The partnership aims to investigate the mechanism of action of pentosan polysulfate sodium (iPPS) on bone marrow lesions, which are linked to pain in osteoarthritis.
Research suggests that Kinesio taping (KT tape) may reduce pain intensity in the immediate and short term, but evidence for long-term benefits and its use in various musculoskeletal conditions is inconclusive. The majority of systematic reviews found inconsistent findings, and potential skin irritation remains a concern.
A systematic review suggests that exercise has small, short-lived effects on knee osteoarthritis pain compared to placebo or no treatment. Moderate certainty evidence indicates negligible effects for hip and small effects for hand osteoarthritis. The findings question the universal promotion of exercise as a first-line treatment.
Researchers used advanced imaging to uncover early molecular changes in bone associated with osteoarthritis. The study found that subchondral bone beneath damaged cartilage showed strong upregulation of specific collagen fragments, suggesting that disease-related bone changes begin earlier than previously recognized.
Research highlights arthritis' toll on the workforce, with nearly 10 million Americans aged 18-64 experiencing limitations. Overall health and socioeconomic factors are significant contributors to work-related challenges.
A new study identifies miR-101a as a critical suppressor of chondrocyte hypertrophy, reducing Cox-2 expression and attenuating structural damage in an OA mouse model. This highlights miR-101a's potential as a therapeutic candidate for osteoarthritis intervention.
A Stanford Medicine-led study discovers an oral treatment that regenerates joint cartilage in old mice, reversing naturally occurring cartilage loss and preventing arthritis. The treatment targets the cause of osteoarthritis, a degenerative joint disease affecting millions worldwide.
The study demonstrates that fexofenadine reduces cartilage degradation, inflammation, and senescence in mice models for OA and IVDD. Pharmacological inhibition of cPLA2 preserves cartilage structure and improves behavioral outcomes.
A new study from researchers at Dell Medical School found that AI-powered tools can improve patient decision-making and outcomes for knee replacement surgery. Patients who used the digital twin tool reported higher decision quality, less regret, and better knee function compared to those who received educational materials alone.
A randomized clinical trial found that an unsupervised online Tai Chi intervention improved knee pain and function compared to the control group at 12 weeks. This free web-based intervention offers a safe, accessible, and scalable option for guideline-recommended osteoarthritis exercise.
Researchers found a significant link between foot/ankle injuries and osteoarthritis in retired pro soccer players. Players who received cortisosteroid injections for injuries were also more likely to develop osteoarthritis.
Regular aerobic exercise improves pain, function, gait performance, and quality of life for patients with knee osteoarthritis. Alternative forms of structured physical activity may still be beneficial when aerobic exercise is not possible.
A new AI system can generate realistic future X-rays alongside risk scores for osteoarthritis progression, giving doctors and patients a clear visual forecast of how the condition may develop over time. The system outperforms comparable tools in predicting osteoarthritis progression with nine times faster speed and accuracy.
A new clinical trial found that patients with mild-to-moderate knee osteoarthritis reported significant reductions in pain and improved physical function after receiving low-dose radiation therapy. The study showed a 70% response rate in the high-dose group, compared to 42% in the placebo group.
Researchers identified five hub genes with high diagnostic performance, showing significant sensitivity and specificity in distinguishing OA from control samples. They predicted targeted drugs with excellent binding interactions, potentially offering therapeutic benefits for OA patients.
A new study reveals that population aging is the largest contributor to musculoskeletal disorders globally, accounting for approximately one third of countries and territories. The research highlights the need for targeted public health strategies and healthcare resource allocation to alleviate the burden of these disorders.
A study found that tirzepatide is more cost-effective than semaglutide for treating knee osteoarthritis and obesity. Tirzepatide offered a more favorable return on investment, making it the better choice for patients.
Researchers have developed an artificial cartilage material that responds to pH changes in the body, releasing anti-inflammatory drugs precisely where and when needed. This approach could improve arthritis treatment outcomes by continuously delivering pain-relieving medication.
A new AI-assisted model combines MRI, biochemical, and clinical information to predict worsening knee osteoarthritis with high accuracy. The model showed improved accuracy in predicting worsening pain and joint space narrowing, suggesting its potential to enhance care.
Aging cells disrupt bone renewal and repair processes, leading to weak bones and joint degeneration. Cellular senescence and inflammation are major drivers of skeletal decline, while senolytics and emerging therapies offer promising new paths for treatment.
A new minimally invasive procedure, genicular artery embolization, has been shown to relieve chronic knee pain caused by osteoarthritis in over 60% of patients. The procedure reduces inflammation and blood flow to joints, providing significant improvements in knee pain and stiffness.
Researchers have developed a new approach to relieving arthritic knee pain through gait retraining, which involves adjusting the angle of a person's foot while walking. The study found that participants experienced pain relief equivalent to medication and showed less knee cartilage degradation over a year.
A new study suggests that subtly adjusting the angle of the foot during walking can reduce knee pain caused by osteoarthritis and slow its progression. By tailoring each patient's foot angle to their unique walking pattern, experts believe an easy and fairly inexpensive way to address early-stage osteoarthritis may be found.
A new study by Bournemouth University reveals that spinning can improve recovery outcomes and reduce clinical time needed for physiotherapy treatment compared to standard care. The cycling and education classes prove more cost-effective, contributing to reducing NHS waiting times for hip osteoarthritis patients.
A new nanocomposite hydrogel system has been developed to address the dual challenges of inflammation and cartilage damage in osteoarthritis. The hydrogel promotes cartilage repair through synergistic immune regulation and chondrocyte differentiation, offering a novel therapeutic strategy for OA.
Researchers have identified WSTF as a protein that could be targeted to block chronic inflammation, allowing the immune system to continue responding appropriately to short-term threats. The study's findings suggest new potential treatments targeting WSTF may combat chronic inflammatory diseases
Researchers investigated the link between HIV treatment regimens and osteoarthritis development, revealing that certain medications like lopinavir can exacerbate OA in the knee. The study's findings have important implications for people living with HIV, highlighting the need to carefully consider treatment options.
Researchers leveraged CRISPR/CasRx to silence Ctnnb1 and Smo, two genes involved in osteoarthritis development. Simultaneous knockdown of both genes effectively mitigated joint structure degeneration, highlighting the potential of RNA-based gene therapies for OA management.
The USC Parris Longevity Accelerator aims to develop early interventions for age-related diseases, including osteoarthritis and cardiovascular disease, through AI-driven diagnostic tools and targeted therapeutics. The initiative could lead to therapies that preserve mobility and restore strength in older adults.
Researchers found that OA cartilage lacks the normal bivalency of repressive and activating histone marks, leading to excessive activation of hypertrophic genes. This results in cartilage breakdown and degeneration. The study provides a potential therapeutic strategy to halt OA progression by targeting epigenetic enzyme KDM6B.
A recent study published in Osteoarthritis and Cartilage reveals that obesity is a leading cause of knee osteoarthritis. The research also found that certain lifestyle changes, such as following a Mediterranean diet and engaging in regular physical activity, can significantly reduce the risk of developing the condition.
A global research initiative analyzing data from nearly 2 million people in diverse populations worldwide has uncovered multiple new genes associated with osteoarthritis. The study also identified key genetic pathways and 69 genes whose protein products are targeted by approved drugs, paving the way for repurposed treatments.
A randomized clinical trial suggests that metformin can be an effective treatment for symptomatic knee osteoarthritis in people with overweight or obesity. The study's results support the use of metformin for this condition, but further confirmation is needed in larger clinical trials.
A study published in JAMA found that metformin reduced knee arthritis pain over six months in patients with symptomatic knee osteoarthritis and overweight or obesity. The treatment was shown to have a moderate effect on pain reduction, with the metformin group reporting a 31.3 point decrease compared to the placebo group.
New research suggests that patients' muscle quality before hip replacement surgery may predict their risk of poor recovery. Patients with poor muscle quality were more likely to perform poorly on movement tasks after surgery, compared to those with good muscle quality.
Researchers at McGill University have identified a potential new treatment for chronic low back pain by targeting 'zombie cells' in the spine. Two drugs, o-Vanillin and RG-7112, were found to clear zombie cells, reduce pain and inflammation, and slow or reverse damage to spinal discs after eight weeks of treatment.
A recent study has made a breakthrough in understanding the genetic underpinnings of osteoarthritis by identifying 962 genetic markers associated with the condition. The researchers found 513 new genetic markers that were not previously reported, providing potential new drug targets and opportunities for repurposing existing medications.
Dr. Elizabeth M. Curtis has been awarded the ESCEO-IOF Pierre Meunier Young Scientist Award for her groundbreaking research on musculoskeletal health and bone disease. Her work focuses on the epidemiology of bone, muscle health, and joint health across the lifespan.
Twelve young researchers from around the world receive ESCEO-IOF Young Investigator Awards for their groundbreaking studies on osteoporosis. The prestigious awards were presented during the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2025) in Rome, Italy.
Professor Atsushi Suzuki, Chair of Endocrinology at Fujita Health University School of Medicine, Japan, received the IOF President's Award for his exceptional contributions to IOF. He has shared his expertise as a mentor and engaged member of the Capture the Fracture Governance.
Dr Ambrish Mithal, an Indian endocrinologist, has been awarded the prestigious IOF CSA Medal of Achievement for his groundbreaking work in advancing the field of osteoporosis. His pioneering efforts have significantly increased understanding and awareness of osteoporosis globally.
A surgical procedure called Birmingham hip resurfacing enables aging athletes to remain highly active, even many years after the procedure. Studies have shown that patients who underwent this procedure were able to return to high-impact sports and maintain their activity levels for an average of 14 years after surgery.
The largest genome-wide association study on osteoarthritis identifies over 900 genetic associations, including 700 genes involved in the disease. These findings offer new insights into the genetic landscape of osteoarthritis and potential drug repurposing opportunities.
PolyU's EmoFriends interactive toy and Transparent Knee Guard wearable device have won the prestigious iF Design Awards 2025 for their cutting-edge sensing technology and emotional support capabilities. The devices demonstrate innovative design solutions for healthcare and technology, showcasing PolyU's commitment to research excellence.
Queen Mary University of London has launched a new regenerative medicine spinout, ReFleks, which aims to repair osteochondral defects and prevent osteoarthritis. The innovative treatment uses Agrin to block cartilage degradation and form new cartilage faster, providing a cheaper and easier alternative to existing approaches.
Researchers at Mass General Brigham have developed a new hydrogel that continuously releases medication without breaking down under mechanical stress. The hydrogel showed promising results in preclinical studies, significantly reducing cartilage damage and improving joint lubrication.